ATI LPN
Pharmacology and the Nursing Process 10th Edition Test Bank
Chapter 47 : Biologic Response?Modifying and Antirheumatic Drugs Questions
Question 1 of 5
A patient has an order for the monoclonal antibody adalimumab. The nurse notes that the patient does not have a history of cancer. What is another possible reason for administering this drug?
Correct Answer: B
Rationale: Monoclonal antibodies are used for the treatment of cancer, rheumatoid arthritis and other inflammatory diseases, multiple sclerosis, and organ transplantation.
Question 2 of 5
During interleukin drug therapy, a patient is showing signs of severe fluid retention, with increasing dyspnea and severe peripheral edema. The next dose of the interleukin is due now. Which action will the nurse take next?
Correct Answer: A
Rationale: The fluid retention that may occur with interleukin therapy is reversible; if therapy is stopped, the prescriber must be notified. The other options are incorrect.
Question 3 of 5
The nurse is administering an interferon and will implement which intervention?
Correct Answer: D
Rationale: Interferon is given parenterally (not orally), and injection sites need to be rotated. Fluids need to be increased during interferon therapy. The other options are incorrect.
Question 4 of 5
Abatacept is prescribed for a patient with severe rheumatoid arthritis. The nurse checks the patient's medical history, knowing that this medication would need to be used cautiously if which condition is present?
Correct Answer: B
Rationale: Abatacept must be used cautiously in patients with recurrent infections or chronic obstructive pulmonary disease. The other options are incorrect.
Question 5 of 5
Aldesleukin (IL-2) is prescribed for a patient. The nurse reviews the patient's medication list and would note a potential drug interaction if which drug class is also ordered?
Correct Answer: D
Rationale: Aldesleukin (IL-2), when given with antihypertensives, can produce additive hypotensive effects. The other responses are incorrect.